U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Imipenem Cilastatin – Injection products
  1. Development Resources

Imipenem Cilastatin – Injection products

 

Minimum Inhibitory
Concentrations

(mcg/mL)

Disk Diffusion
(zone diameter in mm)

Pathogen

S

I

R

S

I

R

Enterobacteralesa

M100 standard is recognized

Pseudomonas aeruginosa

M100 standard is recognized

Acinetobacter spp.

M100 standard is recognized

Haemophilus influenzae and parainfluenzae

M100 standard is recognized

Streptococcus pneumoniae

M100 standard is recognized

 -

-

-

Anaerobes

M100 standard is recognized

-

-

-

aIncluding Salmonella spp. and Shigella spp.

S = Susceptible; I = Intermediate; R = Resistant

Exception to the recognized standard

For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:

Other Non-Enterobacterales

Back to Top